Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Targets-CNS & Neurological Disorders is now published as CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders).

Publisher: Bentham Science Publishers

Volume 2, Number 4, August 2003

Review article

Preface
pp. i-ii(2)
Authors: Rosahl, T. W.; Atack, J. R.

Favourites:
ADD
Favourites:
ADD

GABAA Receptor Subtype Selective Cognition Enhancers
pp. 233-239(7)
Author: Maubach, Karen

Favourites:
ADD
Favourites:
ADD

GABAB Receptors as Potential Therapeutic Targets
pp. 248-259(12)
Authors: Vacher, Claire-Marie; Bettler, Bernhard

Favourites:
ADD

GABAC Receptors as Drug Targets
pp. 260-268(9)
Authors: Johnston, Graham A.R.; Chebib, Mary; Hanrahan, Jane R.; Mewett, Kenneth N.

Favourites:
ADD

GABA Transporters and GABA-Transaminase as Drug Targets
pp. 269-277(9)
Authors: Sarup, Alan; Larsson, Orla Miller; Schousboe, Arne

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more